Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2005
09/22/2005CA2559393A1 Method and apparatus for the detection of microorganisms
09/22/2005CA2559244A1 Method to predict risk of bph progression
09/22/2005CA2559172A1 Therapeutic use of rm1 antigen
09/22/2005CA2559144A1 Estrogen receptor alpha splice variant er-.alpha.36
09/22/2005CA2559124A1 Novel phosphorylated sequences of phosphatase cdc25b, antibodies directed against said sequences and use thereof
09/22/2005CA2559095A1 Temporal or spatial characterization of biosynthetic events in living organisms by isotopic fingerprinting under conditions of imposed isotopic gradients
09/22/2005CA2559060A1 Phospholipases, nucleic acids encoding them and methods for making and using them
09/22/2005CA2558808A1 Classification of breast cancer patients using a combination of clinical criteria and informative genesets
09/22/2005CA2558645A1 Method of optimizing treatment with interferon-tau
09/22/2005CA2558632A1 Improved interleukin-2 muteins
09/22/2005CA2558213A1 Crystal structure of 3',5'-cyclic nucleotide phosphodiesterase (pde10a) and uses thereof
09/22/2005CA2558033A1 Hybrid nanoparticles including an ln2o3 core and having bioligands, and method for preparing same
09/22/2005CA2557633A1 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics
09/22/2005CA2557473A1 Measurement value lowering inhibitor for immunoassay method and immunoassay method using the same
09/22/2005CA2557374A1 Mutant proteins in the dna-binding domain of a trlomeric protein, trf2, and telomeric dna mutants, and use of the complex structure of the trf2 dna-binding domain and telomeric dna
09/22/2005CA2554708A1 Identification and characterization of proteins using new database search modes
09/22/2005CA2528490A1 Method for detecting neoplastic disorders in a solubilized body sample
09/22/2005CA2476028A1 Novel purified polypeptides from staphylococcus pneumoniae
09/21/2005EP1577823A1 A method for identifying unknown proteins by a two-dimensional separation step and the use of markers
09/21/2005EP1577674A1 Recombinant human tsh in the diagnosis of central hypothyroidism
09/21/2005EP1577673A1 The use of BNP-type and ANP-type peptides for assessing the risk of suffering from a cardiovascular complication as a consequence of volume overload
09/21/2005EP1577672A1 Method of analyzing c-terminal amino acid sequence of peptide using mass spectrometry
09/21/2005EP1577671A1 Diagnostic drugs for autoimmune diseases
09/21/2005EP1577670A2 Latent reactive polymers with biologically active moieties
09/21/2005EP1577669A2 Improved electrochemical biosensor test strip
09/21/2005EP1577668A2 Improved elektrochemical biosensor test strip
09/21/2005EP1577665A1 Thin analyzing device
09/21/2005EP1577663A1 Food analyser for self-propelled food loading units, and operating method therefor
09/21/2005EP1577398A1 Method of multiple quantification of cholesterol in low-density lipoproteins
09/21/2005EP1577390A1 Human cancer-relating genes, the products encoded thereby and applications thereof
09/21/2005EP1577389A2 Magnetic pigment
09/21/2005EP1577388A1 Adiponectin promoter and use thereof
09/21/2005EP1577387A1 Preventives/remedies for cancer
09/21/2005EP1577385A1 Marker proteins for diagnosing liver disease and method of diagnosing liver disease using the same
09/21/2005EP1577382A2 Detection of TSE infectivity
09/21/2005EP1577381A1 Tumor/B-cell hybrid cells and uses thereof
09/21/2005EP1577322A1 Novel proteins and use thereof
09/21/2005EP1576524A2 A browsable database for biological use
09/21/2005EP1576394A2 Method using a nonlinear optical technoque for detection of interactions involving a conformational change
09/21/2005EP1576376A2 Isolated communication sample processing system and methods of biological slide processing
09/21/2005EP1576375A1 Synthesis and screening of ligands using x-ray crystallography
09/21/2005EP1576374A2 Enzyme array and assay
09/21/2005EP1576373A1 Inositol phosphate detection assays
09/21/2005EP1576372A1 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a4 (pde9a4)
09/21/2005EP1576371A1 Diagnostic method and assay kit
09/21/2005EP1576370A2 Methods of diagnosing and treating diabetes and insulin resistance
09/21/2005EP1576369A1 Chemically amplified electrochemical detection of affinity reaction
09/21/2005EP1576368A2 Methods of detecting the inhibition of fibrocyte formation and methods and compositions for enhancing fibrocyte formation
09/21/2005EP1576367A1 Analyte test instrument having improved versatility
09/21/2005EP1576366A1 Method for determination of free and combined glycerin in biodiesel
09/21/2005EP1576359A1 Measurement apparatus and method
09/21/2005EP1576354A2 Device for identifying types of sheet materials
09/21/2005EP1576352A2 Methods of cardiovascular disease assessment in an individual
09/21/2005EP1576350A2 Peptides for detection of antibody to a. phagocytophila
09/21/2005EP1576349A2 Molecular diagnosis and prognosis of carcinomas
09/21/2005EP1576190A2 Methods and nucleic acids for the analysis of cpg dinucleotide methylation status associated with the calcitonin gene
09/21/2005EP1576189A1 Vessel, method and apparatus for dissolution testing of an annular pharmaceutical delivery device
09/21/2005EP1576186A1 Method for generating a genetically modified organism for screening active substances
09/21/2005EP1576185A1 Method for detecting mutations
09/21/2005EP1576184A2 Method for the in vitro selection of binders
09/21/2005EP1576183A4 Method for correlating gene expression profiles with protein expression profiles
09/21/2005EP1576183A2 Method for correlating gene expression profiles with protein expression profiles
09/21/2005EP1576181A2 Method for detecting microorganisms
09/21/2005EP1576180A2 Ampk pathway components
09/21/2005EP1576177A2 Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemoresistance
09/21/2005EP1576173A2 Modulators of cellular proliferation
09/21/2005EP1576172A2 Serum protein-associated target-specific ligands and identification method therefor
09/21/2005EP1576170A2 Nucleic acids and corresponding proteins entitled 191p4d12(b) useful in treatment and detection of cancer
09/21/2005EP1576169A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576168A2 Therapeutic polypeptides nucleic acids encoding same and methods of use
09/21/2005EP1576145A2 Bioinformatically detectable group of novel viral regulatory genes and uses thereof
09/21/2005EP1576143A2 Virus-like particles, methods of preparation, and immonogenic compositions
09/21/2005EP1576139A2 Dep-1 receptor protein tyrosine phosphatase interacting proteins and related methods
09/21/2005EP1576134A2 Method for discovering neurogenic agents
09/21/2005EP1576132A2 Nucleic acids and corresponding proteins entitled 273p4b7 useful in treatment and detection of cancer
09/21/2005EP1576131A2 Brain endothelial cell expression patterns
09/21/2005EP1576130A2 Nucleic acids and corresponding proteins entitled 282p1g3 useful in treatment and detection of cancer
09/21/2005EP1576128A2 Products and processes for modulating peptide-peptide binding domain interactions
09/21/2005EP1576126A2 Systems for capture and analysis of biological particles and methods using the systems
09/21/2005EP1576121A2 Determination of protein function
09/21/2005EP1576119A2 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
09/21/2005EP1576117A2 Method of obtaining viable human liver cells, including hepatic stem/progenitor cells
09/21/2005EP1576116A2 Methods and materials relating to novel polypeptides and polynucleotides
09/21/2005EP1576115A2 Protein chips
09/21/2005EP1576110A2 Cell migration inhibiting compositions and methods and compositions for treating cancer
09/21/2005EP1576109A2 Methods and compositions for categorizing patients
09/21/2005EP1576104A2 Nucleic acids and corresponding proteins entitled 202p5a5 useful in treatment and detection of cancer
09/21/2005EP1576102A2 Amidases, nucleic acids encoding them and methods for making and using them
09/21/2005EP1576090A2 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences
09/21/2005EP1576089A2 Expansion of renewable stem cell populations
09/21/2005EP1576087A2 Method for detecting remote homologues and kinases identified with the method
09/21/2005EP1576086A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576012A1 Monoclonal antibody against asialo alpha 1-acid glycoprotein, immunochromatographic strip comprising the monoclonal antibody, and method for diagnosing liver diseases using the immunochromatographic strip
09/21/2005EP1576011A2 Inhibition of il-17 production
09/21/2005EP1576010A2 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix
09/21/2005EP1575997A2 Phosphospecific pak antibodies and diagnostic kits
09/21/2005EP1575996A2 Genes involved in neuropsychiatric disorders
09/21/2005EP1575994A2 Mage-c2 antigenic peptides and uses thereof
09/21/2005EP1575993A2 Methods for treating patients and identifying therapeutics
09/21/2005EP1575989A2 PrP sp sc /sp -INTERACTING MOLECULES AND USES THEREOF
1 ... 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 2050 2051 2052 2053 ... 3937